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ABSTRACT 
Objectives: This study aimed to analyze the associations among depressive/anxiety and pain 
symptoms in patients diagnosed with chronic pain. Methods: Four hundred and fifty-four 
inpatients who were consecutively admitted in a multimodal 3-weeks treatment in a tertiary 
psychosomatic university clinic completed 25 items from the Brief Pain Inventory and the 
Hospital Anxiety and Depression Scale at baseline and after treatment termination. 
Associations among symptoms were explored by network analyses using the graphical least 
absolute shrinkage and selection operator to estimate their partial correlations, while Extended 
Bayesian Information Criterion was used to select the best network solution for the data. We 
explored symptoms’ centrality and expected influence within the network as well as the 
minimum spanning tree for the network. Results: Besides expected associations within 
depressive/anxiety and pain symptoms, the estimated network showed several local 
associations between depressive and pain interference symptoms. The lacks of being cheerful 
and of laughing are two of the depressive symptoms that showed the greatest associations 
with pain interference and a strong centrality within the network. Sleep problems were both 
associated with anxiety/depressive symptoms and pain intensity symptoms. Although at post-
treatment, most of the symptoms showed a significant decrease, the strength of the 
associations between the symptoms within the network were significantly higher than at 
baseline. Discussion: The results support focusing psychosocial interventions in chronic pain 
treatment not only on reducing pain, anxiety and sleep symptoms but also on enhancing 
positive affect. Future research is needed to replicate these findings using repeated within-
person measures designs. 
Conflicts of interests: the authors declare no conflict of interest. 
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INTRODUCTION 
Relationship between depression, anxiety and chronic pain 
Empirical research has shown strong associations among chronic pain (CP) and 
depressive and anxiety symptoms. The percentage of patients with depression is double in 
people with CP (30% vs. 15%) compared to no CP controls, and the prevalence of anxiety 
disorders in CP patients is 50% higher than in controls (21% vs. 14%).
1 
In addition, there is a 
significant correlation between lifetime prevalence of depression and pain incidents.
2
 Pain 
intensity, number of pain locations, and the amount of days with pain are significantly 
associated both with depression and anxiety severity
3
 as well as with the likelihood of being 
diagnosed with depression.
4
 In addition, being diagnosed with a mood or anxiety disorder is 
related to an increase in the likelihood of having pain syndromes concurrently.
2,5
 Furthermore, 
a diagnosis of a CP disorder increases the risk of being diagnosed with an anxiety or 
depressive disorder in the future.
6,7
 Conversely, a previous diagnosis of depression or an 
anxiety disorders is significantly associated with a future diagnosis of chronic pain.
8
 
Symptoms network analysis 
While the link among mood and anxiety disorders and chronic pain has been well 
established in previous research, we lack empirical research to sufficiently understand the 
specific associations between symptoms of chronic pain, anxiety, and depression. Network 
analysis (NA) is a methodology that might enhance our understanding, providing a more fine-
grained analysis at the symptom level that may have direct clinical implications, such as the 
identification of the most important symptom in a network that should be given priority in the 
treatment of chronic pain. 
Recent research in depression has emphasized the potential importance of a symptom-
level instead of a syndrome-level perspective.
9
 For example, individual symptomatology 
analysis have improved the accuracy of mainstream summary strategies based on a broader 
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For other diagnostic groups, network analyses at the symptom level has already helped to 
better understand psychopathological comorbidity patterns (e.g. depression and anxiety,
11
 
social anxiety and eating disorders,
12






The network approach in clinical psychology is founded on an innovative 
psychopathological perspective.
15,16
 Historically, mental disorders have been considered as 
latent (i.e. unobservable) entities that cause an observable constellation of symptoms. For 
example, if someone experiences a combination of depressed mood, anhedonia, apathy, 
abulia, self-reproach tendencies, insomnia, fatigue, and concentration problems this might be 
because the person suffers from a major depressive disorder.
16,17
 This psychopathological 
conceptualization implies, based on the classical medical model of disease causation, that the 
association between the observed symptoms can be explained by the existence of an 
underlying, latent mental disorder.
16
 As a consequence, symptoms need to be independent 
from each other and their association (i.e. its joint occurrence) should disappear if the effect of 
the latent condition is controlled for.
17
 However, the independence of symptoms cannot be 
supported by psychopathology research.
17,18
 For example, in case of a depressed person, it is 
very likely that the experience of a depressed mood may also increase self-reproach 
behaviors, while rumination may contribute to problems in sleeping, which in turn may 
increase the person’s fatigue-level, which may lead to concentration problems.
19
 
To overcome these shortcomings, several authors recently proposed an alternative 
model for explaining the co-occurrence of certain symptoms within and across disorders (i.e. 
comorbidity). In these models, symptoms are conceptualized as being interdependent and 
jointly forming a psychopathological mental condition instead of assuming an underlying 
latent disease or disorder that explains the presence of a number of independent 
symptoms.
15,19,20
 Thus, the network of associations among the symptoms constitutes the 
syndromes and not the other way around.
15
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might have fundamental implications. It means that changes in one symptom might produce 
changes in the other symptoms (and in the whole network), and interventions may try to 
produce changes in the whole network structure by focusing on specific central symptoms.
15,21
 
To analyze systematic associations among symptoms, NA provides a visual and 
statistical tool that paves the way for gathering evidence of the importance of each single 
symptom in the complex network of symptoms.
22
 We are going to provide a more detailed 
explanation of NA in the methods section. 
Network analysis of depressive and anxiety symptoms in chronic pain patients 
In our literature search, we found only few and very recent examples of studies 
analyzing depressive and anxiety symptoms in patients with chronic pain using network 
analysis. McWilliams, Sarty, Kowal, and Wilson
23
 used this method to study the association 
among depressive symptoms in patients with chronic pain. In this study, the most central 
symptoms (in terms of their connectivity within the network
24
) were depressive mood, 
difficulty concentrating, loss of interest, and fatigue. Depressive mood was the symptom with 
the highest strength (i.e., a measure of centrality based on how strong the connections with the 
other symptoms are). Difficulty concentrating was the symptom with the highest closeness 
(i.e., measure of centrality based on distance between the symptoms) and betweenness (i.e., 
measure of centrality based on how important a symptom is to connect others). After 
depressive mood and difficulty concentrating, loss of interest and fatigue symptoms were the 
symptoms with the higher centrality strength, closeness, and betweenness within the network. 
More recently, Thompson, Broadbent, Fuller-Tyszkiewicz, Bertino, and Staiger
25
 used 
complex network analysis to explore the association of anxiety and depression severity with 
pain severity indices (i.e. pain intensity and pain interference with daily life), and fear 
avoidance. Results showed that overall depression severity seemed to play a fundamental role 
within the network, being the construct with the highest strength, and that the associations of 
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perceived pain interference was the construct with the greatest closeness and betweenness 
followed by fear avoidance. 
While the studies by McWilliams et al.
23
 and Thompson et al.
25
 made meaningful 
contributions to our understanding of the complex associations among depressive, anxiety, 
and pain symptoms, the current study builds upon this evidence and tries to further our 
knowledge in several ways. First, McWilliams et al.
23
 conducted fine-grained analyses of 
depressive symptoms in chronic pain patients, but did neither include the core pain 
symptomatology nor anxiety symptoms in their analyses. Second, Thompson et al.
25
 
incorporated both mood and anxiety symptoms as well as pain severity indices, but used 
scale-level information, without exploring the specific associations between single mood, 
anxiety, and pain symptoms. Consequently, while this study supported the idea of 
interrelations among these constructs, focusing on specific associations between single 
symptoms and their relevance might increase our understanding of the complex interplay 
among depression, anxiety, and pain symptoms. 
Thus, the aim of the current study is to analyze the network structure of the 
associations among depressive symptoms, anxiety symptoms, and pain severity indices in 
chronic pain patients. We will first focus on analyzing patients’ baseline network of 
associations among these symptoms (aim #1). Then, we will analyze the symptoms network at 
post-treatment, comparing it with the one identified at baseline (aim #2). Finally, we will 
compare the network structures of responders and non-responders to treatment (aim #3). To 
define responders we followed the suggestions by the Initiative on Methods, Measurement, 
and Pain Assessment in Clinical Trials (IMMPACT
26
). In their consensus statement for 
chronic pain patients, the IMMPACT recommended considering a change as clinically 
relevant if the patient presents a reduction in the sub-scale pain interference with daily life of 
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The results of this study might help to enhance treatments for chronic pain by 
identifying relevant anxiety and depression symptoms that might be targeted by focused 
interventions within a multi-modal treatment. 
MATERIALS AND METHODS 
Participants 
Four hundred fifty-four inpatients being diagnosed with chronic pain disorder with 
somatic and psychological factors (F45.41
27
) who were consecutively admitted into an 
interdisciplinary multimodal treatment program at a tertiary psychosomatic university clinic 
in Switzerland were included in the sample. 
On average, participants were 45.50 years old (SD= 15.04), mostly women (60.9%), 
married (42.6%) or in a relationship (12.7%), and had at least a high school degree (79.2%). 
Most of the participants either were Swiss by birth (58.7%) or naturalized Swiss (27.4%). The 
majority of the sample suffered from pain symptoms for more than a year (84.6%), and more 
than one quarter of the participants for more than 10 years (26.1%). 60.4% of them was 
unable to work. 
Treatment 
Inpatient treatment consisted of a three-week program that comprised different 
multifaceted interventions and therapies. Besides medical interventions and pharmacotherapy, 
the program entailed individual and group physiotherapy. As well patients were enrolled in 
ergotherapy, individual psychotherapy (that consists of cognitive behavioral therapy and 
biofeedback), group psychotherapy (focused on pain management, vertigo/dizziness 
management, communication group), and relaxation training (i.e., mindfulness). 
Measures 
Depression and anxiety symptoms. To assess depression and anxiety 
symptomatology, we used the German version of the Hospital Anxiety and Depression Scale 
(HADS
28
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with physical illnesses or somatoform complaints. The HADS is a self-report instrument, 
rated on a Likert scale from 0 (not at all) to 3 (most of the time). As this measure excludes 
anxiety and depression items that are strongly associated with physical symptoms, it is 
recommended for chronic pain populations 
29
. The HADS assesses the degree of depressive 
and anxiety symptoms during the past week with two subscales (i.e. anxiety and depression) 
that have seven items each. As in this study for the descriptive analyses we used the mean 
subscale score (i.e., total score / number of items responded), the theoretical range of each 
subscale was from 0 to 3. The anxiety subscale includes items such “I feel tense or 'wound 
up'”, while the depression subscale includes items as “I feel as if I am slowed down”. Some 
items included in the HADS represent positive emotions or states (being cheerful, being able 
to laugh, being able to enjoy things, feel relaxed, etc.). In those cases, items were reverse 
scored, assuming that the lack of those positive features represent either depressive or anxiety 
symptoms. The HADS showed adequate psychometric properties with good internal 
consistency, sensitivity and specificity, external validity, and construct validity (showing a 
two-factors structure).
30
 In the current sample, the HADS subscales showed adequate internal 
consistency with Cronbach’s alphas of .77 and .82 for anxiety and depression subscales at 
baseline, respectively. 
Pain symptoms. For pain assessment, we used the German version of the Brief Pain 
Inventory (BPI).
31
 Originally designed to assess cancer pain, the BPI is now frequently used 
as a generic pain questionnaire for various chronic pain conditions.
32
 This self-report measure 
has two subscales to evaluate patient’s pain: pain intensity and pain-related interference in the 
patient’s life. The pain intensity subscale has four items measuring the severity of the pain 
experience that are rated on an 11-point numeric rating scale from 0 (no pain) to 10 (most 
imaginable pain). For example, one item of the pain intensity subscale is “rate your pain by 
marking the number that best describes your pain at its worst in the last 24 hours”. The pain 
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(does not interfere) to 10 (completely interferes). This subscale includes items such as “mark 
the number that describes how, during the past 24 hours, pain has interfered with your general 
activity”. In terms of timeframe, three items of the pain intensity subscale refers to the last 24 
hours (i.e., worst pain, least pain, and average pain), one item of the pain intensity subscale 
refers to the current moment (i.e., current pain), while all the items of the pain interference 
subscale refers to the last week. For the descriptive analyses, we used the mean subscale 
scores (i.e., total score / number of items responded). Both the scores of subscales for pain 
intensity and pain interference had the same theoretical range (although they have different 
amount of items) from 0 to 10. The German version of the BPI has shown good psychometric 
properties with good internal consistency, test-retest reliability, convergent validity, and 
construct validity (consistent with a two-factor structure).
33
 In the current sample, the BPI 
subscales showed adequate internal consistency with Cronbach’s alphas of .82 and .89 for 
intensity and interference subscales, respectively. 
Procedure 
As a standard procedure, patients completed a battery of questionnaires including the 
HADS and BPI at intake and discharge with the help of instructed research assistants. At 
intake, all participants provided informed consent for the use of their data for research 
purposes. The Ethics Committee of the Canton of Bern approved the study (project ID 2018-
00493). 
Analytic strategies 
We conducted all the analyses using R.
34
 Participants included in the analysis had 
completed at least one of the two measures used in this study at baseline. To deal with 




Aim #1: Baseline Network of Depression, Anxiety, and Pain Symptoms. Based on 
the imputed sample, we ran an NA using the R-package bootnet.
36
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represents a pattern of relationships among the included symptoms. The different symptoms 
are named nodes and their relationships are called edges.
16
 The edges could be positive or 
negative, implying direct or inverse associations between the elements of the network. 
Graphically, the nodes are represented by circles and the edges by lines connecting the circles. 
The thickness of the lines represents the strength of the association between the nodes. 
Furthermore, the color of the edges represents the nature of the association between the nodes, 
in terms of direct relationships (usually green or blue) or inverse relationships (usually red). 
Mathematically, the network is formed based on calculating correlations between 
symptoms while controlling for the effects of other symptoms (i.e. partial correlations
37
). We 
used common regularization techniques to reduce the amount of weak edges as well as 
statistical criteria to select the network that best fits the data.
37
 Thereby, the likelihood of 
spurious associations can be limited (i.e. false positives).
22,37
 Thus, to estimate the partial 
correlations within the network, we used a regularization technique named ‘graphical least 
absolute shrinkage and selection operator’ (glasso).
38
 As the glasso method provided several 
networks,
22
 we used the Extended Bayesian Information Criterion to select the optimal 
network.
39
 The EBIC has a hyperparameter (γ) set by the researcher to establish the degree, to 
which the criteria will prioritize sparser or more parsimonious networks. This value ranges 
from 0 to .5, with higher values implying simpler networks.
40
 For this analysis, we set the γ 
parameter at .5, prioritizing the most parsimonious networks.
40
 
Once we had identified the optimal network using this method, we calculated indices 
of symptom centrality within the network. Centrality is a measure of the connectivity of a 
symptom within the network, describing how well the symptom is associated to others in the 
network by estimating the likelihood that the presence (or intensity) of a symptom will trigger 
a systemic activation of the whole network.
41,42
 Three main indices characterize centrality: 
Strength, closeness, and betweenness. Strength assesses how strong the connections among 
symptoms are.
43
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symptoms and might have a greater impact upon them (both positively and negatively). 
Closeness is a measure of distance between a specific symptom and all other symptoms in the 
network.
22
 It is defined as the inverse of the sum of the shortest distance of one node from all 
the other nodes in the network.
43
 Thus, a higher closeness means that a symptom has a shorter 
distance to other symptoms in the network. The effects of changes in symptoms with a high 
closeness are likely to spread more easily within the network.
22
 Finally, Betweenness is a 
measure of how important a symptom is in terms of its connections with other symptoms.
43
 A 
symptom with a high betweenness will often be in on the shortest path between other 
symptoms, linking one symptom to another. Betweenness is an important feature to identify 




We then checked the stability of the centrality indices by using bootstrapping 
procedures (2500 samples) and progressively dropping cases from the sample. Correlation 
stability (CS) indices (i.e. proportion of the sample that can be dropped maintaining a 
correlation of at least .70) above .50 are recommended.
36
 
Considering recent concerns regarding the ability of centrality indices to identify 
relevant symptoms within a network,
45
 we also calculated measures of nodes expected 
influence based on the formulas presented by Robinaugh, Millner, and McNally.
46
 This 
method allows establishing two measures of expected influence. A one-step expected 
influence index that assesses symptoms influence with their direct neighbors, and a two-step 




To further establish symptom relevance within the network, we also ran a Minimum 
Spanning Tree (MST) analysis.
47
 The MST produces a reduced network that connects all the 
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relevance and hierarchical organization.
47,48




Aim #2: Baseline and Post-treatment Network Comparison. For comparison 
purposes we estimated an additional network with the symptoms measured at discharge, and 
compared both networks’ general structure (i.e., the matrices of the networks’ connection 
strength) and global strength invariance (i.e. the sum of all the weighted absolute edges’ 
strength indices in the network) using the package NetworkComparisonTest.
50
 
Aim #3: Comparison between Networks of Responders versus Non-Responders. 
We identified responders and non-responders to treatment and estimated a network for both 
samples at baseline and at post-treatment, using the IMMPACT
26 
criteria described above. 
Once we identified the sample of responders and non-responders by this method, we again 
used the NetworkComparisonTest package to compare (i) the baseline networks of responders 
with non-responders and (ii) the baseline versus post-treatment networks in the group of 
patients who responded to treatment. 
RESULTS 
Sample descriptive statistics 
Mean and standard deviation of all variables are displayed in Table 1, both at baseline 
and at post-treatment. The comparison of baseline and post-treatment levels by paired t-tests 
showed significant differences in three of the pain-intensity items, and in all pain interference, 
anxiety, and depression items (all suggesting a reduction in patients’ severity). When 
adjusting the alpha level due to multiple comparisons using a Bonferroni correction, 20 out of 
the 25 items presented significant reductions during treatment. Of these, one anxiety symptom 
(i.e. restless) and two depression symptoms (i.e. appearance and enjoy TV) did not change 
significantly. Based on IMMPACT criteria, 229 (50.44%) presented a clinically relevant 
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Aim #1: Baseline Network of Depression, Anxiety, and Pain Symptoms 
In Figure 1 we present a graphical representation of the estimated network grouped by 
the subscales of the items. The figure shows several associations between the item groups of 
pain interference and depressive symptoms. Although the pain interference nodes have 
associations with the anxiety symptoms (e.g. restless ↔ sleep, worrying ↔ mood, panic ↔ 
mood), they were weaker than the ones of depressive symptoms (e.g. [lack of being] cheerful 
↔ mood, [lack of being] cheerful ↔ enjoyment, [lack of] laugh ↔ enjoyment). However, as 
it might be expected, there were several associations between anxiety and depression 
symptoms (e.g. relaxed ↔ slowed, tense ↔ slowed, worrying ↔ [lack of being] cheerful). 
The pain intensity symptoms are presented apart from the whole network, they mostly 
do not have direct associations with anxiety or depression symptoms, but only with pain 
interference symptoms. The sleep node, from pain interference, is connected both with pain 
intensity (least and worst pain) and with anxiety nodes (being restless). 
In synthesis, this means that most of the nodes associations were presented between 
pain interference and depression symptoms. Pain intensity nodes were only associated with 
pain interference nodes, being only indirectly associated to depressive and anxiety symptoms. 
Centrality indices. Stability analyses of the centrality measures showed adequate CS 
indices for strength (.67) and closeness (.52), but a low CS index for betweenness (.21). The 
visual inspection of the CS plot (see Supplemental material 1, Supplemental Digital Content 
1, http://links.lww.com/CJP/A613) showed consistent results, with stable correlations for 
strength and closeness (i.e. high level and slow reduction of the correlation when dropping 
cases) but unstable correlations for betweenness (i.e., low levels and steeper reductions in the 
correlations when dropping cases). In Figure 2, we present the distribution of the standardized 
centrality indices of strength and closeness (i.e., the indices that showed reliable results) for 
all the nodes in the network. The nodes with the highest strength centrality were [lack of] 
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is another enjoyment item within the depression symptoms, i.e. enjoyment-d), and average 
(pain intensity symptom). These nodes were the ones that presented the strongest connections 
within the network, having the greater impact upon the other network’s nodes. The highest 
closeness scores were associated with mood (pain interference symptom), enjoyment-pi (pain 
interference symptom), and [lack of being] cheerful (depressive symptom)
a
. Thus, these nodes 
were the ones that presented the shortest distance with other nodes within the network, 
meaning that changes in them would spread more easily within the network. 
Expected influence indices. We presented the results of the expected influences 
indices at Table 2. Consistent with the results of the centrality indices, the nodes with the 
greatest expected influence (both in one-step and two-step methods, ordered by ranking) 
where [lack of] laugh (depressive symptom), enjoyment-pi (pain interference symptom), and 
average (pain intensity symptom). Mood (pain intensity symptom) was the fourth node with 
greatest expected influence with the one-step method and the fifth node with greatest expected 
influence with the two-step method. The node [lack of being] cheerful (depressive symptom) 
was the fifth node with greatest expected influence with the one-step method and the fourth 
node with greatest expected influence with the two-step method. The results of these indices 
suggest that the symptoms [lack of] laugh, enjoyment-pi, average, mood, and [lack of being] 
cheerful are the ones with both greatest immediate influence (i.e., with their direct neighbors) 
and secondary influence (i.e., via their neighbors’ further influences). 
Minimum Spanning Tree Analyses. In Supplemental material 2, Supplemental 
Digital Content 2, http://links.lww.com/CJP/A614 we present the results of the minimum 
spanning tree analyses. The MST distribution is consistent with the observed baseline network 
                                                 
a
 We replicate these findings running exactly the same models but using standardized scores for the items, to 
control for any biased due to the differential ranges of the nodes
51
. The network estimated with this variation 
presented the same three nodes with the greatest centrality strength ([lack of] laugh, enjoyment-pi, and average) 
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of Figure 1. In all cases, the items of the same sub-scales were grouped together. The main 
node connecting the branches of the MST (connecting with the depression, anxiety, and pain 
interference symptoms) and likely being central in the network is the [lack of being] cheerful 
item of the depression sub-scale. Overall, the MST showed that depression symptoms 
connected anxiety and pain symptoms (interference and intensity). Furthermore, pain intensity 
symptoms are connected to the network via pain interference symptoms. Thus, pain 
interference symptoms (especially enjoyment, mood, and sleep interference symptoms) also 
connected pain intensity and depression symptoms. Particularly, the pain interference 
symptom of sleep connects the pain interference symptoms with pain intensity nodes. 
Aim #2: Baseline and Post-treatment Network Comparison 
The test of network invariance between baseline and post-treatment data approached 
significance (M statistic = 0.21, p = .065). Additionally, the global strength invariance test 
showed a significant difference between the baseline and post-treatment networks (S statistic 
= 1.27, p < .001). The nodes from the baseline network presented a lower global strength 
(Mean = 10.60) than the nodes from the post-treatment network (Mean = 11.86). Thus, the 
global strength of the network tend to increase from baseline to post-treatment. 
Aim #3: Comparison between Networks of Responders versus Non-Responders 
When comparing baseline networks of responders versus non-responders we did not 
find a significant difference in the network structure (M statistic = 0.21, p = .35). However, 
there was a significant difference in networks’ global strength (S statistic = 2.65, p = .003). 
The nodes in the non-responders’ network showed a greater overall strength (Mean = 10.76) 
than the responders’ network (Mean = 8.11). 
Then, we compared the networks of responders at baseline with the same patients’ 
networks at post-treatment. We did not find a significant difference between baseline and 
post-treatment network structure (M statistic = 0.20, p = .54). However, there was a 
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the responders’ network at post-treatment had a greater overall strength (Mean = 12.31) than 
the baseline responders’ network (Mean = 8.11). 
DISCUSSION 
The aim of the current study was to analyze the network structure of depression 
symptoms, anxiety symptoms, and pain severity indices in patients with chronic pain. We first 
ran a network analysis using baseline data from chronic pain patients. The results from the 
network analysis showed the greatest centrality and expected influence in the nodes [lack of] 
laughing, enjoyment (pain interference), average pain, [lack of being] cheerful, and mood. 
Second, we compared the network structure of the whole sample at baseline versus at post-
treatment, finding that the post-treatment networks present a significantly greater node’s 
strength compared to the baseline network. Thus, patients tended to increase their network 
strength during treatment. Third, we compared the baseline networks in responders versus 
non-responders and, in patients that responded to treatment, comparing baseline and post-
treatment networks. The non-responders’ network nodes presented a significantly greater 
strength than the responders’ network. However, the responders’ network at post-treatment 
had a significantly greater strength than the baseline responders’ network. These results 
suggest that treatment non-responders tend to have a more strongly connected network at 
baseline, while responders tend to have weaker associations within their network. 
Nevertheless, the patients that respond to treatment tend to increase the strength of nodes 
association from baseline to post-treatment. To facilitate the comprehension of the findings 
we included a summary of the main results of the study in the Supplemental material 3, 
Supplemental Digital Content 3, http://links.lww.com/CJP/A615. 
Baseline Network of Depression, Anxiety, and Pain Symptoms 
Overall, the results of the network analyses at baseline showed that pain interference 
and depressive symptoms were most central. Consistently, in a network analysis in chronic 
pain, Thompson et al.
25
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symptomatology and pain interference were the ones with greatest centrality. In the current 
paper, we used a more fine-grained symptom-level analysis rather than an overall sub-scale 
approach as the one of Thompson et al.
25
, that allowed us to disaggregate specific symptoms 
within the estimated network and specify their single relevance. The symptoms with the 
greatest centrality (i.e., strength and closeness) in the network were the depressive symptoms 
of (not) laughing and (not) being cheerful, as well as the pain interference items of (lacking) 




From a clinical standpoint, symptoms with a high strength and a high expected 
influence bear the promise to be good candidates for therapeutic targets,
11,46
 because a change 
in these symptoms is more likely to have a greater impact on reducing other symptoms within 
the network of depression symptoms, anxiety symptoms, and pain symptoms.
24,52
 For 
example, trying to help the patient to increase the number of enjoyable experiences in his or 
her life with a greater potential for (genuine) laughter may be a promising target being 
associated with greater changes in pain interferences. Also, the findings regarding closeness 
centrality indices may have important clinical implications. Because changes in symptoms 
with high closeness are more likely to spread more quickly within the network, symptoms 
with high closeness may also be promising therapeutic targets (especially if they have a 
substantive strength) and may be associated with a quicker systemic change by targeted 
interventions.
43
 For example, as (not being) cheerful had high closeness indices within the 
network, interventions that help patients to experience more cheerful mood states are likely to 
have a more widespread beneficial impact on other network symptoms, particularly the pain 
interference experiences, compared to nodes with lower closeness scores. 
Thus, the four items with greatest centrality (i.e., [lack of] laugh, [lack of being] 
cheerful, enjoyment, and mood) may produce the strongest and quickly spreading effects on 
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candidates for psychosocial interventions in the treatment of patients with chronic pain. 
However, this study represents only a first step in the identification of potential 
depressive/anxiety and pain symptoms that might be relevant targets for the treatment of 
chronic pain patients. Further research would be necessary to replicate these findings and 
identify sound symptom targets of clinical interventions for pain. 
It is worth to highlight that the depressive symptoms presenting the greatest 
associations with pain interference and the greatest centrality and expected influence within 
the network describe the absence of positive psychological states (i.e. cheerful and laugh), and 
not only the presence of negative states. These results are in line with a growing body of 
research associating resilience resources with better coping strategies and attitudes towards 
chronic pain.
53,54
 Specifically, positive affect, has been identified as a resilience mechanism 
associated with higher levels of coping responses, perceived self-efficacy and overall mental 
health in patients with chronic pain.
54,55
 Furthermore, these findings might support the 
importance of following a capitalization model when treating chronic pain, that aims to work 
on activating the patients’ strengths as the main mechanism of change (e.g., aiming to 
improve their capacities of being cheerful and having more humorous experiences), and not 
only a compensation model that focuses on modifying patients’ deficits or vulnerabilities.
56,57
 
The depressive symptoms also presented strong connections with the anxiety 
symptoms, partially linking anxiety symptoms with the rest of the network. These results are 
also consistent with those of Thompson et al.
25
 at a construct level. Additionally, they are in 
line with a strong body of research indicating the close relationships between anxiety and 





well as the growing importance of unified protocols to treat them.
61,62
 
Pain intensity items turned out to be separated from the other nodes of the network, 
being only connected with depression/anxiety symptoms via pain interference items. 
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intensity and anxiety symptoms. It might be possible that higher pain intensity is particularly 
interfering and that anxiety symptoms were related if there are sleep problems involved. This 
is consistent with previous research showing associations between the intensity of chronic 
pain and sleep problems
63
 as well as evidence suggesting a reciprocal relationship between 
both phenomena.
64
 Thus, sleep problems might be a pivotal “connector” between pain 
intensity and anxiety, and may be potentially important for therapy or for prevention 
programs. These fine-grained symptom-level findings are also consistent with results by 
Thompson et al.
25
 who reported that pain interference symptoms connect pain intensity with 
the whole network of symptoms. These findings might further support the relevance of 
interference pain symptoms for the multimodal treatment of chronic pain. 
The MST analysis generally confirmed the above results and provided additional 
information on the differential topological relevance of the nodes in the network. Besides 
confirming some of the relationships among the groups of items (i.e. depression symptoms 
linking anxiety symptoms with the rest of the network and pain interference linking pain 
intensity with the whole structure), the MST highlighted the importance of (not being) 
cheerful as a core depressive symptom connecting pain interference, anxiety, and depression. 
Baseline and Post-treatment Network Comparison 
Whereas symptom distress scores were significantly reduced after treatment and the 
network structure remained relatively stable from pre to post treatment, the general strength of 
the associations among the nodes in the network increased over the rather short inpatient 
treatment (on average, three-weeks). The finding that the network structure remained stable 
from baseline to post-treatment has also been observed in other short-term interventions.
11
 
This might imply that the overall symptom structure cannot be modified substantially during a 
short-term multimodal inpatient treatment of chronic pain. The insignificant difference in the 
network structure between baseline and post-treatment symptoms is in line with this 
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increase in network strength from baseline to post-treatment also replicates previous studies 
showing an increase of item intercorrelations (i.e., higher connectivity in the network models) 
over time in different clinical settings.
11,52
 This pattern has been consistent between different 
ranges of time (i.e., for 6 weeks to 2 years) and different sources of clinical information 
(patients self-reported and clinician-rated measures) and was also associated with a reduction 
of scale dimensionality and an increase in reliability within scales over time.
52
 Although the 
authors of these papers explored several statistical and psychometric explanations (e.g., lack 
of normal distribution, floor or ceiling effects, spurious effects due to measurement bias), they 
refuted all of them because they did not fit their data, failing to find a likely cause to 
understand this finding.
11,52
 Further research might need to replicate the finding of an 
increased network strength from baseline to post-treatment and continue exploring different 
statistical, psychometric, and clinical explanations and test them empirically, to fully 
understand the implications of this finding. 
Comparison between Networks of Responders versus Non-Responders 
The comparison between the baseline scores of responders vs. non-responders, and 
between the networks of responders at baseline vs. post-treatment suggests additional clinical 
implication for the treatment of chronic pain patients. On the one hand, patients who did not 
respond to treatment had a greater baseline strength of associations within the networks in 
comparison to patients who responded. This finding, consistent with previous theoretical and 
empirical studies
15,65
, underlines the importance of evaluating patients’ baseline network of 
symptomatic associations as predictor of treatment outcome, considering that having a 
strongly interconnected symptom structure at baseline seems to impede the success of a 
multimodal inpatient treatment for chronic pain. A more intense repeated-measures analysis 
of the associations between symptoms at baseline within each patient might not only provide 
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could also inform on likely profitable symptom targets for an individual patient
14
, providing 
key information for personalized treatments of chronic pain patients. 
As noted above, the comparison between responders’ baseline and post-treatment 
networks showed an increase of the strength of the associations within the symptoms. In other 
words, whereas having looser symptom associations seems to facilitate symptom change 
during inpatient multimodal treatment for chronic pain, the symptom structure of successfully 
treated patients seems to consolidate over treatment. Understanding the quality of less 
pathological / more changeable symptom structures could provide further guidance to 
treatment development for chronic pain. 
Limitations and Future Directions 
Several limitations characterize this study. First, the study analyzed only chronic pain 
and depression/anxiety symptoms. Further psychopathological phenomena might be included 
to evaluate chronic pain syndrome networks in more detail (e.g. past adverse/traumatic events 
or personality disorder traits). The lack of a direct measurement of positive affect or resilience 
features related to chronic pain symptomatology, represents another limitation of the study. 
Future research might need to explore the associations among depression/anxiety symptoms, 
chronic pain symptoms, and other psychopathological as well as resilience phenomena in 
more detail. Second, we only analyzed cross-sectional data at two time points, i.e., at baseline 
and post-treatment, limiting the potential for deriving causal inferences in terms of symptoms 
associations. As a consequence, the observed relationships between the symptoms rather need 
to be interpreted as being interdependent over time. Following Granger’s causality model
66,67
, 
future studies might need to implement a more intensive repeated-measure assessment of 
depression/anxiety symptoms and chronic pain symptoms, with methods like Ecological 
Momentary Assessment
68
, evaluating cross-lagged associations among symptoms. Third, we 
only analyzed a short-term three-week inpatient treatment for chronic pain. The short-term 
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baseline and post-treatment networks. Further research, analyzing treatments for chronic pain 
that may also include day-hospital or outpatient treatments, might provide stronger evidence 
for the structural evolution of symptom networks during chronic pain treatment. Fourth, the 
low stability of the betweenness centrality index limited us in the possibility of drawing 
robust conclusions on relevant symptoms in terms of mediated relationships among 
symptoms. Finally, the network analysis was focused only on analyzing symptom-level and 
symptom-interference nodes. Whereas this data might inform clinical practice from a 
psychopathological perspective (i.e. symptoms and symptom-interferences that are relevant 
within the network), it does not inform about other clinically and therapeutically relevant 
variables that are associated both with the network and change during treatment, e.g. patient 
expectations or motivation to treatment. 
Besides these limitations, this study provides relevant information on pain, depression, 
and anxiety symptoms associations in patients with chronic pain. Furthermore, the findings 
have the potential to inform treatment development, particularly supporting a capitalization 
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Figure legends 
FIGURE 1. Network analysis of the association among pain and depressive/anxiety 
symptoms. Note. Enjoym.PI = Enjoyment (Pain Interference sub-scale), Enjoym.D = 
Enjoyment (Depression sub-scale), Appear. = Appearance (Depression sub-scale), Butterf. = 
Butterflies (Anxiety sub-scale), Enjoy_TV = Enjoy television. All the edges in the Figure are 
positive, with the exception of Restless <-> Walking, Restless <-> [lack of] Laugh, Restless 
<-> Appearance, and Butterflies <-> Walking. 
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(n = 454) 
 
Post-treatment 
(n = 335) 
Baseline to Post-treatment 
differences 
 
M SD  M SD t(273/334)
a
 p 
Pain Intensity 5.60 1.84  5.25 2.02 3.33 .001 
Worst 7.45 1.99  6.89 2.22 4.77 < .001 
Least 3.86 2.16  3.71 2.25 0.41 .68 
Average 5.72 1.92  5.24 2.09 4.20 < .001 
Current 5.36 2.36  5.15 2.38 0.66 .51 
Pain Interference 5.97 1.90  4.86 2.17 10.30 < .001 
Activity 6.57 2.39  5.44 2.50 7.21 < .001 
Mood 6.09 2.76  4.98 2.74 6.63 < .001 
Walking 5.15 3.14  4.29 2.99 4.60 < .001 
Work 6.72 2.49  5.57 2.73 6.22 < .001 
Relations 5.05 3.15  3.65 2.98 7.04 < .001 
Sleep 6.31 3.12  5.41 3.21 5.04 < .001 
Enjoyment-PI 6.02 2.98  4.54 2.98 8.99 < .001 
Anxiety 1.52 0.64  1.21 0.66 10.66 < .001 
Tense 1.89 0.95  1.28 0.87 10.98 < .001 
Awful 1.41 1.20  1.13 1.11 3.70 < .001 
Worrying 1.74 1.01  1.36 1.01 6.92 < .001 
Relaxed 1.78 0.91  1.44 0.89 6.77 < .001 
Butterflies 1.25 1.02  1.02 0.94 3.42 .001 
Restless 1.49 1.06  1.34 0.94 2.87 .004 
Panic 1.17 1.01  0.93 0.89 4.69 < .001 
 
Depression 1.42 0.67  1.10 0.67 11.07 < .001 
Enjoy 1.61 1.06  1.11 0.90 8.99 < .001 
Laugh 1.25 .91  0.88 0.84 7.04 < .001 
Cheerful 1.43 .97  1.12 0.97 6.03 < .001 
Slowed 2.19 .91  1.75 0.90 8.31 < .001 
Appearance 1.00 1.07  0.86 1.00 2.07 .039 
Enjoyment-D 1.58 1.02  1.18 0.96 8.05 < .001 
Enjoy_TV 0.98 1.02  0.78 0.88 3.16 .002 
Note: 
a
 Paried t-tests for pain symptoms had 273 degrees of freedom, while the paired t-
tests for anxiety/depressive symptoms had 334 degrees of freedom. A Bonferroni 
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Worst Pain Intensity 0.77 18 1.55 15 
Least Pain Intensity 0.88 13 1.75 11 
Average Pain Intensity 1.19 3 2.18 3 
Current Pain Intensity 0.89 11 1.75 12 
Activity Pain Interference 1.01 8 1.86 9 
Mood Pain Interference 1.08 4 2.09 5 
Walking Pain Interference 0.63 23 1.21 23 
Work Pain Interference 0.89 12 1.65 14 
Relations Pain Interference 0.65 21 1.34 21 
Sleep Pain Interference 0.54 24 1.01 24 
Enjoyment-PI Pain Interference 1.20 2 2.30 2 
Tense Anxiety 0.79 17 1.47 18 
Awful Anxiety 1.06 6 1.97 6 
Worrying Anxiety 0.86 15 1.73 13 
Relaxed Anxiety 0.87 14 1.54 17 
Butterflies Anxiety 0.81 16 1.55 16 
Restless Anxiety 0.45 25 0.82 25 
Panic Anxiety 1.03 7 1.95 7 
Enjoy Depression 0.97 9 1.91 8 
Laugh Depression 1.23 1 2.34 1 
Cheerful Depression 1.07 5 2.14 4 
Slowed Depression 0.65 22 1.23 22 
Appearance Depression 0.67 20 1.36 20 
Enjoyment-D Depression 0.91 10 1.77 10 
Enjoy TV Depression 0.71 19 1.42 19 
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SUPPLEMENTAL MATERIAL 3. Summary of the main results of the study 
Baseline network 
Correlation stability of the centrality indices 
Strength = .67 / Closeness = .52 / Between = .21 
Nodes with greatest strength centrality 
Laugh / Enjoyment-PI / Average pain 
Nodes with greatest  closeness centrality 
Mood / Enjoyment-PI / Cheerful 
Nodes with greatest one-step expected influence 
Laugh / Enjoyment-PI  / Average pain 
Nodes with greatest one-step expected influence 
Laugh /  Enjoyment-PI / Average pain 
Minimum spanning tree most central nodes 
Cheerful / Laugh / Enjoyment-PI 
Baseline and post-treatment network comparison 
Global strength 
Baseline mean strength = 10.60 
Post-treatment mean strength = 11.86 
S statistic = 1.27, p < .001 
Responders versus non-responders baseline network comparison 
Global strength 
Non-responders baseline mean strength = 10.76 
Responders baseline mean strength = 8.11 
S statistic = 2.65, p = .003 
Responders baseline and post-treatment network comparison 
Global strength 
Baseline responders mean strength = 8.11 
Post-treatment  responders mean strength = 12.31 
S statistic = 4.20, p < .001 
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